Status:
RECRUITING
PET-CT Predicting Segement Specific Lymph Nodes Metastasis
Lead Sponsor:
Fudan University
Conditions:
Non Small Cell Lung Cancer
Lymph Node Metastasis
Eligibility:
All Genders
20-80 years
Brief Summary
This study is a multicenter prospective clinical study that aims to evaluate the predictive value of preoperative PET-CT results (such as SUV uptake, size of tumor lymph nodes, and differences in FDG ...
Eligibility Criteria
Inclusion
- Solitary tumor, or multiple tumors with only ground-glass nodules (GGNs) apart from the primary lesion.
- Diameter of the primary lesion ≤5cm, with a CTR between 0.5 and 1.
- No enlarged mediastinal lymph nodes observed on preoperative contrast-enhanced CT.
- Pathological confirmation of non-small cell lung cancer (NSCLC) either before or during surgery.
- Systematic lymph node dissection performed during surgery.
- No prior radiotherapy or chemotherapy for initial treatment.
- No history of malignant tumors.
Exclusion
- Locally advanced or distant metastasis.
- Pleural dissemination observed during surgery.
- History of malignant tumors.
- Received neoadjuvant therapy.
- Systematic lymph node dissection not performed during surgery.
- Histopathological examination reveals lung malignancies other than non-small cell lung cancer (NSCLC).
Key Trial Info
Start Date :
November 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
280 Patients enrolled
Trial Details
Trial ID
NCT05970913
Start Date
November 1 2023
End Date
December 1 2024
Last Update
August 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shanghai Cancer Center
Shanghai, China